Eva Ulrika Sjökvist Saers

Currently, Eva Ulrika Sjökvist Saers is Chairman at Dicot Pharma AB since 2021, Chairman at SWElife since 2020, Chairman at Oxcia AB since 2025, Chairman at Coegin Pharma AB since 2023, Director at Bluefish Pharmaceuticals AB, Independent Director at Alligator Bioscience AB since 2021, Director at ApoEx AB, Deputy Director at Brainstorm AB, Director at Empowered Applications AB, and Independent Director at NextCell Pharma AB since 2024.
Formerly, the role of Chief Executive Officer was held at Apotek Produktion & Laboratorier AB from 2008 to 2018 and at Apotekets Omstrukturering AB. Vice Chairman at SwedenBIO Service AB was from 2011 to 2020.
The position of Chairman was held at The Swedish Academy, Swedish Pharmaceutical Society, Swedish Academy For Pharmaceutical Sciences, and Apotekarsocieteten.
Director roles were held at Karo Healthcare AB, Apoteket AB from 2005 to 2008, AstraZeneca AB from 1999 to 2003, Recipharm AB, Karolinska Institutet Holding AB, IDL Biotech AB, Dilafor AB, Astra Pain Control AB from 1993 to 1999, and Apl Fastigheter AB. Education includes graduate and doctorate degrees from the University of Uppsala.